Literature DB >> 33064007

Nanoenabled Intracellular Calcium Bursting for Safe and Efficient Reversal of Drug Resistance in Tumor Cells.

Junjie Liu1,2,3, Chunyu Zhu1, Lihua Xu1, Danyu Wang1, Wei Liu1,2,3, Kaixiang Zhang1,2,3, Zhenzhong Zhang1,2,3, Jinjin Shi1,2,3.   

Abstract

Multidrug resistance (MDR) of a tumor is the main cause of failure of clinical chemotherapy. Herein, we report a simple, yet versatile, tumor-targeting "calcium ion nanogenerator" (TCaNG) to reverse drug resistance by inducing intracellular Ca2+ bursting. Consequently, the TCaNG could induce Ca2+ bursting in acidic lysosomes of tumor cells and then reverse drug resistance according to the following mechanisms: (i) Ca2+ specifically accumulates in mitochondria, suppressing cellular respiration and relieving tumor hypoxia, thus inhibiting P-glycoprotein biosynthesis by downregulating HIF-1α expression. (ii) Ca2+-bursting-induced respiratory depression blocks intracellular ATP production, which further leads to the P-gp incompetence. As a result, the TCaNG could decrease the IC50 of DOX to MCF-7/ADR cells by approximately 30 times and reduce the proliferation of drug-resistant tumors by approximately 13 times without obvious side effects. This simple, safe, and effective "Ca2+ bursting" strategy holds the potential for clinical application in tumor treatment.

Entities:  

Keywords:  calcium interference; calcium ion nanogenerator; intracellular Ca2+ bursting; reversal of drug resistance

Mesh:

Substances:

Year:  2020        PMID: 33064007     DOI: 10.1021/acs.nanolett.0c03042

Source DB:  PubMed          Journal:  Nano Lett        ISSN: 1530-6984            Impact factor:   11.189


  11 in total

1.  Copper-based metal-organic framework impedes triple-negative breast cancer metastasis via local estrogen deprivation and platelets blockade.

Authors:  Sijie Wang; Na Yin; Yongjuan Li; Tingting Xiang; Wenxiao Jiang; Xiu Zhao; Wei Liu; Zhenzhong Zhang; Jinjin Shi; Kaixiang Zhang; Xingming Guo; Pilei Si; Junjie Liu
Journal:  J Nanobiotechnology       Date:  2022-07-06       Impact factor: 9.429

Review 2.  Recent advances in anti-multidrug resistance for nano-drug delivery system.

Authors:  Changduo Wang; Fashun Li; Tianao Zhang; Min Yu; Yong Sun
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 3.  Recent progress in nanomedicine for enhanced cancer chemotherapy.

Authors:  Guoqing Wei; Yu Wang; Guang Yang; Yi Wang; Rong Ju
Journal:  Theranostics       Date:  2021-04-19       Impact factor: 11.556

Review 4.  Ion Interference Therapy of Tumors Based on Inorganic Nanoparticles.

Authors:  Yongjie Chi; Peng Sun; Yuan Gao; Jing Zhang; Lianyan Wang
Journal:  Biosensors (Basel)       Date:  2022-02-06

5.  Cetuximab-Modified Human Serum Albumin Nanoparticles Co-Loaded with Doxorubicin and MDR1 siRNA for the Treatment of Drug-Resistant Breast Tumors.

Authors:  Xin Yang; Yifan Wang; Si Chen; Shuang Zhang; Chunying Cui
Journal:  Int J Nanomedicine       Date:  2021-10-16

6.  Targeted delivery and stimulus-responsive release of anticancer drugs for efficient chemotherapy.

Authors:  Lei Qiao; Xue Yuan; Hui Peng; Guisong Shan; Min Gao; Xiaoqing Yi; Xiaoyan He
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

7.  Bone mineral: A trojan horse for bone cancers. Efficient mitochondria targeted delivery and tumor eradication with nano hydroxyapatite containing doxorubicin.

Authors:  Yang Liu; Aftab Nadeem; Sujeesh Sebastian; Martin A Olsson; Sun N Wai; Emelie Styring; Jacob Engellau; Hanna Isaksson; Magnus Tägil; Lars Lidgren; Deepak Bushan Raina
Journal:  Mater Today Bio       Date:  2022-02-26

8.  Combating multidrug resistance and metastasis of breast cancer by endoplasmic reticulum stress and cell-nucleus penetration enhanced immunochemotherapy.

Authors:  Weixi Jiang; Li Chen; Xun Guo; Chen Cheng; Yuanli Luo; Jingxue Wang; Junrui Wang; Yang Liu; Yang Cao; Pan Li; Zhigang Wang; Haitao Ran; Zhiyi Zhou; Jianli Ren
Journal:  Theranostics       Date:  2022-03-21       Impact factor: 11.600

9.  Phytic acid-modified CeO2 as Ca2+ inhibitor for a security reversal of tumor drug resistance.

Authors:  Zhimin Tian; Junlong Zhao; Shoujie Zhao; Huicheng Li; Zhixiong Guo; Zechen Liang; Jiayuan Li; Yongquan Qu; Dongfeng Chen; Lei Liu
Journal:  Nano Res       Date:  2022-01-29       Impact factor: 10.269

Review 10.  Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management.

Authors:  Ping Jin; Jingwen Jiang; Li Zhou; Zhao Huang; Edouard C Nice; Canhua Huang; Li Fu
Journal:  J Hematol Oncol       Date:  2022-07-18       Impact factor: 23.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.